Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
11.27
+0.24 (2.18%)
Jul 3, 2026, 3:00 PM CST
Jiangsu Yahong Meditech Revenue
Jiangsu Yahong Meditech had revenue of 71.09M CNY in the quarter ending March 31, 2026, with 16.34% growth. This brings the company's revenue in the last twelve months to 287.11M, up 20.46% year-over-year. In the year 2025, Jiangsu Yahong Meditech had annual revenue of 277.12M with 37.49% growth.
Revenue (ttm)
287.11M
Revenue Growth
+20.46%
P/S Ratio
22.08
Revenue / Employee
577.68K
Employees
497
Market Cap
6.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 277.12M | 75.56M | 37.49% |
| Dec 31, 2024 | 201.56M | 187.81M | 1,365.55% |
| Dec 31, 2023 | 13.75M | 13.73M | 52,604.89% |
| Dec 31, 2022 | 26.10K | 21.52K | 470.51% |
| Dec 31, 2021 | 4.57K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.13B |
| China Animal Husbandry Industry | 6.45B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Cisen Pharmaceutical | 3.37B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| Shandong Wit Dyne Health | 2.02B |
| Guangxi Wuzhou Zhongheng Group | 1.58B |
| Beijing Sun-Novo Pharmaceutical Research | 1.19B |